As of Q4'25, CVS reported cash and short-term investments of USD 8.45B and total debt of USD 79.95B. This latest data point reflects a continued gap between cash reserves and debt levels at the end of the period. From Q1'23 to Q4'25, the chart shows that CVS’s cash and short-term investments experienced notable volatility, peaking at USD 17.72B in Q1'23 before declining to USD 8.45B by Q4'25, with several fluctuations in between. In contrast, the company’s debt remained consistently high, ranging from USD 76.48B to USD 83.82B, with only minor variations over the observed quarters. The persistent disparity between cash and debt highlights ongoing leverage, with no significant trend toward deleveraging during this period.